Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Detection Inks Benelux Distribution Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular Detection today said that it has signed an agreement with Dutch firm Westburg BV to be the exclusive distributor of the firm's Detect-Ready MRSA panel in the Benelux region.

The Wayne, Pa.-based firm also said that the real-time PCR-based test has been CE-Marked for detection of both methicillin-resistant Staphylococcus aureus and methicillin-sensitive S, aureus. It said that the screening test enables physicians to distinguish the two types of infections.

"We anticipate launch in the Benelux region shortly, at which time our Detect-Ready MRSA panel will be available in 10 markets worldwide," David Wilson, MDI's VP for commercial operations, Europe, said in a statement.

The Detect-Ready MRSA panel is currently sold in the UK, Germany, Ireland, Switzerland, Spain, Austria, and Australia.

Financial and other terms of the agreement were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.